| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 62 | 2013 | 5767 | 2.040 |
Why?
|
| Mice, Transgenic | 47 | 2016 | 4143 | 0.910 |
Why?
|
| Prostate | 14 | 2016 | 1088 | 0.810 |
Why?
|
| Adenocarcinoma | 24 | 2009 | 7789 | 0.700 |
Why?
|
| Receptors, Androgen | 11 | 2012 | 878 | 0.530 |
Why?
|
| Receptor, IGF Type 1 | 3 | 2010 | 347 | 0.410 |
Why?
|
| Mice | 64 | 2016 | 34495 | 0.400 |
Why?
|
| Fibroblast Growth Factors | 2 | 2003 | 257 | 0.390 |
Why?
|
| Mice, Inbred C57BL | 31 | 2013 | 6942 | 0.390 |
Why?
|
| Receptors, Fibroblast Growth Factor | 4 | 2003 | 153 | 0.380 |
Why?
|
| Disease Models, Animal | 22 | 2013 | 7222 | 0.380 |
Why?
|
| Apoptosis | 13 | 2013 | 7591 | 0.350 |
Why?
|
| Prostatic Hyperplasia | 4 | 2008 | 210 | 0.340 |
Why?
|
| Disease Progression | 21 | 2013 | 6682 | 0.340 |
Why?
|
| Neovascularization, Pathologic | 7 | 2009 | 1547 | 0.330 |
Why?
|
| CD8-Positive T-Lymphocytes | 7 | 2012 | 1586 | 0.330 |
Why?
|
| Animals | 67 | 2016 | 59536 | 0.330 |
Why?
|
| Androgens | 7 | 2008 | 511 | 0.310 |
Why?
|
| Cell Transformation, Neoplastic | 6 | 2011 | 2359 | 0.310 |
Why?
|
| Transforming Growth Factor beta | 6 | 2012 | 1130 | 0.300 |
Why?
|
| Epithelium | 3 | 2008 | 720 | 0.300 |
Why?
|
| Gene Expression Regulation, Neoplastic | 14 | 2012 | 8873 | 0.290 |
Why?
|
| Gene Deletion | 2 | 2008 | 1442 | 0.270 |
Why?
|
| Genes, Retinoblastoma | 1 | 2004 | 86 | 0.250 |
Why?
|
| Neurosecretory Systems | 1 | 2004 | 66 | 0.240 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2004 | 110 | 0.230 |
Why?
|
| Drug Screening Assays, Antitumor | 3 | 2008 | 566 | 0.230 |
Why?
|
| Milk Proteins | 1 | 2003 | 116 | 0.230 |
Why?
|
| Growth Substances | 1 | 2004 | 300 | 0.230 |
Why?
|
| Male | 65 | 2016 | 123000 | 0.220 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2004 | 311 | 0.210 |
Why?
|
| Trans-Activators | 3 | 2012 | 1555 | 0.210 |
Why?
|
| Cyclins | 1 | 2004 | 456 | 0.210 |
Why?
|
| Tretinoin | 1 | 2004 | 623 | 0.210 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2003 | 280 | 0.200 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2008 | 639 | 0.200 |
Why?
|
| Cell Division | 7 | 2008 | 2489 | 0.180 |
Why?
|
| Cell Cycle | 2 | 2011 | 2084 | 0.170 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2013 | 235 | 0.170 |
Why?
|
| Pyrroles | 1 | 2003 | 576 | 0.170 |
Why?
|
| Genes, p53 | 1 | 2003 | 1090 | 0.170 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 4 | 2013 | 84 | 0.170 |
Why?
|
| Genetic Therapy | 2 | 2003 | 1616 | 0.170 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 5 | 2007 | 96 | 0.170 |
Why?
|
| Indoles | 2 | 2005 | 1009 | 0.160 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2011 | 1331 | 0.160 |
Why?
|
| Cell Differentiation | 4 | 2003 | 4078 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2006 | 1493 | 0.160 |
Why?
|
| Immune Tolerance | 4 | 2009 | 403 | 0.150 |
Why?
|
| Cell Line, Tumor | 13 | 2013 | 14551 | 0.150 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2003 | 2488 | 0.150 |
Why?
|
| Piperazines | 1 | 2006 | 2101 | 0.150 |
Why?
|
| Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases | 1 | 2016 | 13 | 0.140 |
Why?
|
| Epithelial Cells | 3 | 2016 | 1818 | 0.140 |
Why?
|
| Nuclear Proteins | 3 | 2012 | 3343 | 0.140 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2003 | 1248 | 0.140 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 3 | 2003 | 661 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2009 | 272 | 0.130 |
Why?
|
| Histone Acetyltransferases | 2 | 2007 | 411 | 0.130 |
Why?
|
| Integrases | 2 | 2008 | 262 | 0.130 |
Why?
|
| Sialoglycoproteins | 2 | 2005 | 151 | 0.120 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 3 | 2009 | 992 | 0.120 |
Why?
|
| DNA-Binding Proteins | 2 | 2003 | 4821 | 0.120 |
Why?
|
| Integrin beta4 | 1 | 2013 | 22 | 0.110 |
Why?
|
| Beverages | 1 | 2013 | 105 | 0.110 |
Why?
|
| Adoptive Transfer | 4 | 2012 | 446 | 0.110 |
Why?
|
| Mucositis | 1 | 2013 | 148 | 0.110 |
Why?
|
| Cell Proliferation | 9 | 2013 | 7226 | 0.110 |
Why?
|
| Mice, Knockout | 9 | 2013 | 5710 | 0.110 |
Why?
|
| Dendritic Cells | 3 | 2009 | 1085 | 0.110 |
Why?
|
| Signal Transduction | 11 | 2013 | 11965 | 0.110 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2012 | 23 | 0.110 |
Why?
|
| Lipocalins | 1 | 2012 | 54 | 0.100 |
Why?
|
| COUP Transcription Factor I | 1 | 2012 | 81 | 0.100 |
Why?
|
| Immunohistochemistry | 8 | 2010 | 7548 | 0.100 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2012 | 81 | 0.100 |
Why?
|
| Metalloproteins | 1 | 2011 | 26 | 0.100 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2012 | 219 | 0.100 |
Why?
|
| Neoplastic Stem Cells | 2 | 2013 | 1443 | 0.100 |
Why?
|
| Gene Targeting | 2 | 2013 | 292 | 0.100 |
Why?
|
| Rats | 7 | 2016 | 6086 | 0.100 |
Why?
|
| Antigens, Neoplasm | 2 | 2008 | 1506 | 0.090 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2006 | 4757 | 0.090 |
Why?
|
| Organogenesis | 2 | 2008 | 119 | 0.090 |
Why?
|
| Scutellaria | 1 | 2009 | 6 | 0.090 |
Why?
|
| Organ Specificity | 2 | 2008 | 699 | 0.090 |
Why?
|
| Cloning, Molecular | 2 | 2010 | 1213 | 0.090 |
Why?
|
| Simian virus 40 | 2 | 2007 | 137 | 0.090 |
Why?
|
| Diet | 3 | 2013 | 1440 | 0.090 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2009 | 48 | 0.090 |
Why?
|
| Stem Cells | 1 | 2016 | 1213 | 0.090 |
Why?
|
| Membrane Proteins | 2 | 2011 | 2819 | 0.080 |
Why?
|
| Carcinoma | 2 | 2013 | 2578 | 0.080 |
Why?
|
| Genetic Engineering | 2 | 2007 | 288 | 0.080 |
Why?
|
| Plant Extracts | 2 | 2007 | 215 | 0.080 |
Why?
|
| Immunologic Surveillance | 1 | 2008 | 60 | 0.080 |
Why?
|
| Killer Cells, Natural | 1 | 2013 | 904 | 0.080 |
Why?
|
| Scorpion Venoms | 1 | 2007 | 15 | 0.080 |
Why?
|
| Carbocyanines | 1 | 2007 | 41 | 0.080 |
Why?
|
| Serenoa | 1 | 2007 | 1 | 0.080 |
Why?
|
| Cell Adhesion Molecules | 1 | 2010 | 577 | 0.080 |
Why?
|
| Fibrosarcoma | 1 | 2008 | 135 | 0.080 |
Why?
|
| Prunus africana | 1 | 2007 | 1 | 0.080 |
Why?
|
| 5-alpha Reductase Inhibitors | 1 | 2007 | 20 | 0.080 |
Why?
|
| Androgen Antagonists | 2 | 2007 | 411 | 0.070 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2013 | 1299 | 0.070 |
Why?
|
| Phytosterols | 1 | 2007 | 31 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 4 | 2010 | 3101 | 0.070 |
Why?
|
| Luciferases, Firefly | 1 | 2006 | 39 | 0.070 |
Why?
|
| Receptors, Immunologic | 1 | 2008 | 309 | 0.070 |
Why?
|
| Enzyme Activation | 3 | 2008 | 1764 | 0.070 |
Why?
|
| Aurora Kinase B | 1 | 2006 | 68 | 0.070 |
Why?
|
| Phytotherapy | 1 | 2007 | 110 | 0.070 |
Why?
|
| Aurora Kinases | 1 | 2006 | 189 | 0.070 |
Why?
|
| Ultrasonography, Doppler | 1 | 2007 | 231 | 0.070 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2006 | 182 | 0.070 |
Why?
|
| Cellular Senescence | 1 | 2008 | 382 | 0.070 |
Why?
|
| Receptors, Pituitary Hormone-Regulating Hormone | 1 | 2005 | 4 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2007 | 2508 | 0.070 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2008 | 238 | 0.070 |
Why?
|
| Receptors, Neuropeptide | 1 | 2005 | 27 | 0.070 |
Why?
|
| Up-Regulation | 4 | 2006 | 2450 | 0.070 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2007 | 503 | 0.070 |
Why?
|
| Soybean Proteins | 1 | 2005 | 20 | 0.070 |
Why?
|
| Carcinogens | 1 | 2006 | 384 | 0.070 |
Why?
|
| Morphogenesis | 1 | 2007 | 337 | 0.070 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2005 | 55 | 0.070 |
Why?
|
| Antineoplastic Agents | 2 | 2007 | 14289 | 0.070 |
Why?
|
| Genes, Neoplasm | 1 | 2007 | 324 | 0.070 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2009 | 673 | 0.060 |
Why?
|
| Biomarkers, Tumor | 4 | 2012 | 10331 | 0.060 |
Why?
|
| Genistein | 1 | 2005 | 73 | 0.060 |
Why?
|
| Aurora Kinase A | 1 | 2006 | 202 | 0.060 |
Why?
|
| Regeneration | 1 | 2008 | 279 | 0.060 |
Why?
|
| Protein Kinases | 2 | 2006 | 874 | 0.060 |
Why?
|
| Integrin beta1 | 1 | 2005 | 126 | 0.060 |
Why?
|
| Mice, SCID | 3 | 2016 | 1869 | 0.060 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2008 | 726 | 0.060 |
Why?
|
| Molecular Sequence Data | 3 | 2009 | 6089 | 0.060 |
Why?
|
| Neoplasms, Experimental | 1 | 2008 | 750 | 0.060 |
Why?
|
| DNA Primers | 2 | 2004 | 1399 | 0.060 |
Why?
|
| Humans | 26 | 2013 | 261506 | 0.060 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2009 | 1033 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2008 | 1439 | 0.060 |
Why?
|
| Proteins | 2 | 2003 | 1963 | 0.060 |
Why?
|
| Antigens, Polyomavirus Transforming | 3 | 2011 | 110 | 0.060 |
Why?
|
| Melanoma, Experimental | 2 | 2005 | 368 | 0.060 |
Why?
|
| Antigens, CD | 2 | 2008 | 1385 | 0.060 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2005 | 299 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 3 | 2010 | 5395 | 0.060 |
Why?
|
| Epigenesis, Genetic | 1 | 2010 | 1399 | 0.060 |
Why?
|
| Ligands | 2 | 2003 | 995 | 0.060 |
Why?
|
| Androgen-Binding Protein | 1 | 2002 | 39 | 0.060 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2003 | 367 | 0.060 |
Why?
|
| Fibroblast Growth Factor 7 | 1 | 2002 | 30 | 0.060 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2003 | 223 | 0.060 |
Why?
|
| Serpins | 1 | 2003 | 77 | 0.050 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2003 | 60 | 0.050 |
Why?
|
| Amino Acid Sequence | 2 | 2009 | 4233 | 0.050 |
Why?
|
| STAT5 Transcription Factor | 1 | 2003 | 214 | 0.050 |
Why?
|
| Autocrine Communication | 1 | 2002 | 84 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2008 | 1538 | 0.050 |
Why?
|
| Microcirculation | 1 | 2003 | 200 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2003 | 125 | 0.050 |
Why?
|
| Serine Endopeptidases | 1 | 2004 | 275 | 0.050 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2003 | 167 | 0.050 |
Why?
|
| Contrast Media | 1 | 2009 | 1472 | 0.050 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2002 | 27 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2003 | 259 | 0.050 |
Why?
|
| Keratins | 1 | 2003 | 330 | 0.050 |
Why?
|
| Nuclear Matrix | 1 | 2002 | 21 | 0.050 |
Why?
|
| Paracrine Communication | 1 | 2002 | 128 | 0.050 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2003 | 301 | 0.050 |
Why?
|
| Neoplasm Proteins | 2 | 2005 | 3230 | 0.050 |
Why?
|
| Reference Values | 1 | 2004 | 1099 | 0.050 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2003 | 334 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2003 | 875 | 0.050 |
Why?
|
| Base Sequence | 2 | 2008 | 4917 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2003 | 371 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2003 | 842 | 0.050 |
Why?
|
| Lymphoma, B-Cell | 1 | 2008 | 895 | 0.050 |
Why?
|
| Age Factors | 2 | 2008 | 5377 | 0.050 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 2 | 2013 | 56 | 0.050 |
Why?
|
| Doxorubicin | 1 | 2008 | 3005 | 0.050 |
Why?
|
| Ovarian Follicle | 1 | 2002 | 152 | 0.050 |
Why?
|
| Zebrafish Proteins | 1 | 2002 | 163 | 0.050 |
Why?
|
| Bone Neoplasms | 1 | 2013 | 2576 | 0.050 |
Why?
|
| Binding Sites | 1 | 2005 | 2171 | 0.050 |
Why?
|
| Neoplasms | 3 | 2013 | 15193 | 0.050 |
Why?
|
| RNA, Messenger | 5 | 2011 | 6150 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2003 | 507 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2010 | 3639 | 0.050 |
Why?
|
| Germ-Line Mutation | 1 | 2005 | 1046 | 0.050 |
Why?
|
| Cadherins | 1 | 2003 | 660 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2009 | 1648 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2003 | 554 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2007 | 1879 | 0.040 |
Why?
|
| Lung Neoplasms | 4 | 2013 | 11538 | 0.040 |
Why?
|
| Phosphorylation | 4 | 2011 | 4804 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2012 | 5159 | 0.040 |
Why?
|
| Mutation | 4 | 2012 | 15179 | 0.040 |
Why?
|
| Transfection | 4 | 2005 | 2944 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 2003 | 1694 | 0.040 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 3 | 2003 | 182 | 0.040 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2003 | 986 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 3 | 2008 | 2314 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2003 | 1459 | 0.040 |
Why?
|
| Protein Biosynthesis | 1 | 2002 | 889 | 0.040 |
Why?
|
| Ovary | 1 | 2002 | 668 | 0.040 |
Why?
|
| Mice, Inbred CBA | 2 | 2009 | 78 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 3203 | 0.040 |
Why?
|
| T-Cell Antigen Receptor Specificity | 2 | 2008 | 107 | 0.040 |
Why?
|
| Transgenes | 3 | 2003 | 557 | 0.040 |
Why?
|
| Castration | 2 | 2010 | 122 | 0.040 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 4557 | 0.040 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2002 | 1242 | 0.040 |
Why?
|
| Neoplasm Transplantation | 2 | 2013 | 1519 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2016 | 2063 | 0.030 |
Why?
|
| Species Specificity | 2 | 2007 | 777 | 0.030 |
Why?
|
| Cell Growth Processes | 2 | 2007 | 342 | 0.030 |
Why?
|
| T-Lymphocytes | 2 | 2008 | 3869 | 0.030 |
Why?
|
| Transplantation, Heterologous | 2 | 2010 | 1082 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2003 | 1756 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2004 | 2045 | 0.030 |
Why?
|
| Homeostasis | 2 | 2013 | 950 | 0.030 |
Why?
|
| Orchiectomy | 2 | 2007 | 214 | 0.030 |
Why?
|
| T-Lymphocytes, Cytotoxic | 3 | 2005 | 1016 | 0.030 |
Why?
|
| Alleles | 3 | 2008 | 2437 | 0.030 |
Why?
|
| Osteopontin | 2 | 2005 | 148 | 0.030 |
Why?
|
| Organ Size | 2 | 2007 | 690 | 0.030 |
Why?
|
| Spleen | 2 | 2006 | 676 | 0.030 |
Why?
|
| Retroviridae | 2 | 2005 | 332 | 0.030 |
Why?
|
| Receptors, Tumor Necrosis Factor, Member 25 | 1 | 2012 | 3 | 0.030 |
Why?
|
| In Situ Hybridization | 2 | 2007 | 1037 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2007 | 5270 | 0.030 |
Why?
|
| Neoplasm Staging | 2 | 2006 | 13658 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 2010 | 2927 | 0.030 |
Why?
|
| Crosses, Genetic | 2 | 2003 | 241 | 0.030 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 2005 | 229 | 0.030 |
Why?
|
| Goblet Cells | 1 | 2013 | 135 | 0.030 |
Why?
|
| Immunization | 2 | 2005 | 397 | 0.030 |
Why?
|
| Random Allocation | 1 | 2013 | 703 | 0.030 |
Why?
|
| Cell Survival | 2 | 2009 | 3045 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 2 | 2005 | 694 | 0.030 |
Why?
|
| Tripartite Motif Proteins | 1 | 2011 | 55 | 0.030 |
Why?
|
| Cell Adhesion | 2 | 2005 | 1008 | 0.020 |
Why?
|
| Lymphatic Metastasis | 2 | 2013 | 4844 | 0.020 |
Why?
|
| Nutritional Status | 1 | 2013 | 337 | 0.020 |
Why?
|
| Gene Order | 1 | 2011 | 111 | 0.020 |
Why?
|
| Female | 9 | 2013 | 141928 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2011 | 260 | 0.020 |
Why?
|
| Adrenomedullin | 1 | 2012 | 104 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2011 | 394 | 0.020 |
Why?
|
| Ultrasonography | 2 | 2009 | 1863 | 0.020 |
Why?
|
| Neoplasm Metastasis | 3 | 2009 | 5112 | 0.020 |
Why?
|
| Testosterone | 2 | 2007 | 619 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2013 | 905 | 0.020 |
Why?
|
| Methotrexate | 1 | 2013 | 999 | 0.020 |
Why?
|
| Survival Rate | 1 | 2003 | 12221 | 0.020 |
Why?
|
| Down-Regulation | 2 | 2005 | 2074 | 0.020 |
Why?
|
| Diarrhea | 1 | 2013 | 686 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2013 | 419 | 0.020 |
Why?
|
| Immunotherapy, Adoptive | 2 | 2009 | 1763 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2003 | 1064 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2009 | 385 | 0.020 |
Why?
|
| CD40 Ligand | 1 | 2009 | 115 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2012 | 621 | 0.020 |
Why?
|
| CD40 Antigens | 1 | 2009 | 104 | 0.020 |
Why?
|
| Body Weight | 1 | 2013 | 1293 | 0.020 |
Why?
|
| Benz(a)Anthracenes | 1 | 2008 | 9 | 0.020 |
Why?
|
| Receptors, Natural Killer Cell | 1 | 2008 | 17 | 0.020 |
Why?
|
| Methylcholanthrene | 1 | 2008 | 29 | 0.020 |
Why?
|
| Silymarin | 1 | 2007 | 2 | 0.020 |
Why?
|
| Antigen-Presenting Cells | 1 | 2009 | 284 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 1077 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2007 | 40 | 0.020 |
Why?
|
| Synaptophysin | 1 | 2007 | 79 | 0.020 |
Why?
|
| Sexual Maturation | 1 | 2008 | 65 | 0.020 |
Why?
|
| Immunodominant Epitopes | 1 | 2008 | 61 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2007 | 139 | 0.020 |
Why?
|
| Blotting, Western | 2 | 2005 | 3536 | 0.020 |
Why?
|
| 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2007 | 18 | 0.020 |
Why?
|
| RNA Interference | 1 | 2012 | 1408 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2006 | 4971 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2007 | 110 | 0.020 |
Why?
|
| Dihydrotestosterone | 1 | 2007 | 118 | 0.020 |
Why?
|
| Antigens, Differentiation | 1 | 2008 | 238 | 0.020 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2007 | 54 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2011 | 1489 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2007 | 256 | 0.020 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2006 | 157 | 0.020 |
Why?
|
| Antibodies | 1 | 2009 | 838 | 0.020 |
Why?
|
| Prostatic Secretory Proteins | 1 | 2005 | 6 | 0.020 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2006 | 93 | 0.020 |
Why?
|
| Antigen Presentation | 1 | 2007 | 272 | 0.020 |
Why?
|
| Nuclear Receptor Coactivator 1 | 1 | 2007 | 236 | 0.020 |
Why?
|
| Novobiocin | 1 | 2005 | 8 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 2006 | 148 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 2216 | 0.020 |
Why?
|
| CD3 Complex | 1 | 2006 | 314 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2007 | 886 | 0.020 |
Why?
|
| CD146 Antigen | 1 | 2005 | 57 | 0.020 |
Why?
|
| Anticarcinogenic Agents | 1 | 2007 | 362 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2006 | 448 | 0.020 |
Why?
|
| Glycosylation | 1 | 2005 | 213 | 0.020 |
Why?
|
| Survival | 1 | 2005 | 177 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2011 | 1265 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 568 | 0.020 |
Why?
|
| Point Mutation | 1 | 2008 | 769 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2007 | 459 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2009 | 669 | 0.020 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2005 | 65 | 0.020 |
Why?
|
| Growth Hormone | 1 | 2005 | 226 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2013 | 3981 | 0.020 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2007 | 383 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2007 | 769 | 0.020 |
Why?
|
| Biomarkers | 1 | 2016 | 5047 | 0.020 |
Why?
|
| Gene Expression | 1 | 2013 | 3570 | 0.020 |
Why?
|
| Antioxidants | 1 | 2007 | 507 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2006 | 666 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2005 | 331 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2005 | 869 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2009 | 925 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2006 | 798 | 0.010 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 2003 | 20 | 0.010 |
Why?
|
| CTLA-4 Antigen | 1 | 2008 | 657 | 0.010 |
Why?
|
| Photons | 1 | 2007 | 507 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2007 | 741 | 0.010 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2003 | 113 | 0.010 |
Why?
|
| Thioredoxins | 1 | 2003 | 50 | 0.010 |
Why?
|
| Ovalbumin | 1 | 2003 | 254 | 0.010 |
Why?
|
| Receptor, ErbB-2 | 1 | 2013 | 2518 | 0.010 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2003 | 231 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 2006 | 842 | 0.010 |
Why?
|
| Laminin | 1 | 2003 | 194 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2003 | 287 | 0.010 |
Why?
|
| Prognosis | 2 | 2012 | 21713 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2008 | 2315 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2007 | 1338 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2005 | 1062 | 0.010 |
Why?
|
| Fibronectins | 1 | 2003 | 197 | 0.010 |
Why?
|
| Frizzled Receptors | 1 | 2002 | 25 | 0.010 |
Why?
|
| Corpus Luteum | 1 | 2002 | 32 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 1489 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2005 | 630 | 0.010 |
Why?
|
| Cancer Vaccines | 1 | 2008 | 697 | 0.010 |
Why?
|
| Hyperplasia | 1 | 2003 | 557 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2006 | 1144 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2002 | 289 | 0.010 |
Why?
|
| Microdissection | 1 | 2001 | 86 | 0.010 |
Why?
|
| Prostate-Specific Antigen | 1 | 2005 | 993 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2008 | 1498 | 0.010 |
Why?
|
| Early Detection of Cancer | 1 | 2009 | 1258 | 0.010 |
Why?
|
| Granulosa Cells | 1 | 2002 | 146 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2005 | 803 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2003 | 613 | 0.010 |
Why?
|
| Aged | 3 | 2013 | 70117 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2010 | 2669 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2003 | 837 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2005 | 1620 | 0.010 |
Why?
|
| Wnt Proteins | 1 | 2002 | 397 | 0.010 |
Why?
|
| Time Factors | 2 | 2005 | 12926 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2005 | 1152 | 0.010 |
Why?
|
| MAP Kinase Signaling System | 1 | 2003 | 848 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2008 | 2022 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2003 | 1113 | 0.010 |
Why?
|
| Middle Aged | 3 | 2013 | 86204 | 0.010 |
Why?
|
| Testis | 1 | 2003 | 717 | 0.010 |
Why?
|
| Forkhead Transcription Factors | 1 | 2003 | 778 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 4938 | 0.010 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2002 | 488 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2009 | 2967 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2002 | 862 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2003 | 1555 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2006 | 3821 | 0.010 |
Why?
|
| Cell Line | 1 | 2005 | 5114 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2003 | 1533 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2003 | 1546 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2003 | 1682 | 0.010 |
Why?
|
| Cytokines | 1 | 2006 | 2809 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2003 | 2054 | 0.010 |
Why?
|
| Glioma | 1 | 2007 | 1963 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 3719 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2003 | 5637 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2002 | 3154 | 0.010 |
Why?
|
| Young Adult | 1 | 2010 | 21445 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2005 | 5539 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 29902 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2007 | 4849 | 0.010 |
Why?
|
| Adolescent | 1 | 2010 | 31252 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 2005 | 4654 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2003 | 7702 | 0.000 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2002 | 6550 | 0.000 |
Why?
|
| Adult | 1 | 2010 | 77950 | 0.000 |
Why?
|